Skin Cancer Diagnosis and Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 109 pages | ID: S4E132F4A4AEEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Skin Cancer Diagnosis and Therapeutics in Global, including the following market information:

Global Skin Cancer Diagnosis and Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Skin Cancer Diagnosis and Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Actinic Keratoses (AK) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Skin Cancer Diagnosis and Therapeutics include Agilent, Amgen, Aqua Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo, Elekta, Eli Lilly and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Skin Cancer Diagnosis and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Skin Cancer Diagnosis and Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Skin Cancer Diagnosis and Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Actinic Keratoses (AK)
• Based cell carcinoma (BCC)
• Squamous cell carcinoma (SCC)
• Melanoma

Global Skin Cancer Diagnosis and Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Skin Cancer Diagnosis and Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Cancer research centers
• Clinics

Global Skin Cancer Diagnosis and Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Skin Cancer Diagnosis and Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Skin Cancer Diagnosis and Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Skin Cancer Diagnosis and Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Agilent
• Amgen
• Aqua Pharmaceuticals
• AstraZeneca
• Bristol-Myers Squibb
• Daiichi Sankyo
• Elekta
• Eli Lilly
• Roche
• GSK
• iCAD
• Bausch Health
• Merck
• Novartis
• Pfizer
• QIAGEN
• Sanofi
• Teva Pharmaceutical
• Varian Medical Systems

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Skin Cancer Diagnosis and Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Skin Cancer Diagnosis and Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Skin Cancer Diagnosis and Therapeutics Market Size: 2021 VS 2028
2.2 Global Skin Cancer Diagnosis and Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Skin Cancer Diagnosis and Therapeutics Players in Global Market
3.2 Top Global Skin Cancer Diagnosis and Therapeutics Companies Ranked by Revenue
3.3 Global Skin Cancer Diagnosis and Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Skin Cancer Diagnosis and Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Skin Cancer Diagnosis and Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Skin Cancer Diagnosis and Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Skin Cancer Diagnosis and Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Skin Cancer Diagnosis and Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Skin Cancer Diagnosis and Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Actinic Keratoses (AK)
  4.1.3 Based cell carcinoma (BCC)
  4.1.4 Squamous cell carcinoma (SCC)
  4.1.5 Melanoma
4.2 By Type - Global Skin Cancer Diagnosis and Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Skin Cancer Diagnosis and Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Skin Cancer Diagnosis and Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Skin Cancer Diagnosis and Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Cancer research centers
  5.1.4 Clinics
5.2 By Application - Global Skin Cancer Diagnosis and Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Skin Cancer Diagnosis and Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Skin Cancer Diagnosis and Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Skin Cancer Diagnosis and Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Skin Cancer Diagnosis and Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Skin Cancer Diagnosis and Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Skin Cancer Diagnosis and Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Skin Cancer Diagnosis and Therapeutics Revenue, 2017-2028
  6.3.2 US Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.3.3 Canada Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Skin Cancer Diagnosis and Therapeutics Revenue, 2017-2028
  6.4.2 Germany Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.3 France Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.5 Italy Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.6 Russia Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Skin Cancer Diagnosis and Therapeutics Revenue, 2017-2028
  6.5.2 China Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.5.3 Japan Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.5.6 India Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Skin Cancer Diagnosis and Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Skin Cancer Diagnosis and Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.7.3 Israel Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.7.5 UAE Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Agilent
  7.1.1 Agilent Corporate Summary
  7.1.2 Agilent Business Overview
  7.1.3 Agilent Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.1.4 Agilent Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Agilent Key News
7.2 Amgen
  7.2.1 Amgen Corporate Summary
  7.2.2 Amgen Business Overview
  7.2.3 Amgen Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.2.4 Amgen Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Amgen Key News
7.3 Aqua Pharmaceuticals
  7.3.1 Aqua Pharmaceuticals Corporate Summary
  7.3.2 Aqua Pharmaceuticals Business Overview
  7.3.3 Aqua Pharmaceuticals Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.3.4 Aqua Pharmaceuticals Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Aqua Pharmaceuticals Key News
7.4 AstraZeneca
  7.4.1 AstraZeneca Corporate Summary
  7.4.2 AstraZeneca Business Overview
  7.4.3 AstraZeneca Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.4.4 AstraZeneca Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 AstraZeneca Key News
7.5 Bristol-Myers Squibb
  7.5.1 Bristol-Myers Squibb Corporate Summary
  7.5.2 Bristol-Myers Squibb Business Overview
  7.5.3 Bristol-Myers Squibb Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.5.4 Bristol-Myers Squibb Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Bristol-Myers Squibb Key News
7.6 Daiichi Sankyo
  7.6.1 Daiichi Sankyo Corporate Summary
  7.6.2 Daiichi Sankyo Business Overview
  7.6.3 Daiichi Sankyo Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.6.4 Daiichi Sankyo Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Daiichi Sankyo Key News
7.7 Elekta
  7.7.1 Elekta Corporate Summary
  7.7.2 Elekta Business Overview
  7.7.3 Elekta Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.7.4 Elekta Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Elekta Key News
7.8 Eli Lilly
  7.8.1 Eli Lilly Corporate Summary
  7.8.2 Eli Lilly Business Overview
  7.8.3 Eli Lilly Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.8.4 Eli Lilly Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Eli Lilly Key News
7.9 Roche
  7.9.1 Roche Corporate Summary
  7.9.2 Roche Business Overview
  7.9.3 Roche Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.9.4 Roche Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Roche Key News
7.10 GSK
  7.10.1 GSK Corporate Summary
  7.10.2 GSK Business Overview
  7.10.3 GSK Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.10.4 GSK Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 GSK Key News
7.11 iCAD
  7.11.1 iCAD Corporate Summary
  7.11.2 iCAD Business Overview
  7.11.3 iCAD Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.11.4 iCAD Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 iCAD Key News
7.12 Bausch Health
  7.12.1 Bausch Health Corporate Summary
  7.12.2 Bausch Health Business Overview
  7.12.3 Bausch Health Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.12.4 Bausch Health Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.12.5 Bausch Health Key News
7.13 Merck
  7.13.1 Merck Corporate Summary
  7.13.2 Merck Business Overview
  7.13.3 Merck Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.13.4 Merck Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.13.5 Merck Key News
7.14 Novartis
  7.14.1 Novartis Corporate Summary
  7.14.2 Novartis Business Overview
  7.14.3 Novartis Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.14.4 Novartis Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.14.5 Novartis Key News
7.15 Pfizer
  7.15.1 Pfizer Corporate Summary
  7.15.2 Pfizer Business Overview
  7.15.3 Pfizer Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.15.4 Pfizer Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.15.5 Pfizer Key News
7.16 QIAGEN
  7.16.1 QIAGEN Corporate Summary
  7.16.2 QIAGEN Business Overview
  7.16.3 QIAGEN Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.16.4 QIAGEN Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.16.5 QIAGEN Key News
7.17 Sanofi
  7.17.1 Sanofi Corporate Summary
  7.17.2 Sanofi Business Overview
  7.17.3 Sanofi Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.17.4 Sanofi Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.17.5 Sanofi Key News
7.18 Teva Pharmaceutical
  7.18.1 Teva Pharmaceutical Corporate Summary
  7.18.2 Teva Pharmaceutical Business Overview
  7.18.3 Teva Pharmaceutical Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.18.4 Teva Pharmaceutical Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.18.5 Teva Pharmaceutical Key News
7.19 Varian Medical Systems
  7.19.1 Varian Medical Systems Corporate Summary
  7.19.2 Varian Medical Systems Business Overview
  7.19.3 Varian Medical Systems Skin Cancer Diagnosis and Therapeutics Major Product Offerings
  7.19.4 Varian Medical Systems Skin Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.19.5 Varian Medical Systems Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Skin Cancer Diagnosis and Therapeutics Market Opportunities & Trends in Global Market
Table 2. Skin Cancer Diagnosis and Therapeutics Market Drivers in Global Market
Table 3. Skin Cancer Diagnosis and Therapeutics Market Restraints in Global Market
Table 4. Key Players of Skin Cancer Diagnosis and Therapeutics in Global Market
Table 5. Top Skin Cancer Diagnosis and Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Skin Cancer Diagnosis and Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Skin Cancer Diagnosis and Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Skin Cancer Diagnosis and Therapeutics Product Type
Table 9. List of Global Tier 1 Skin Cancer Diagnosis and Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Skin Cancer Diagnosis and Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Skin Cancer Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Skin Cancer Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Skin Cancer Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Skin Cancer Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Agilent Corporate Summary
Table 31. Agilent Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 32. Agilent Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Corporate Summary
Table 34. Amgen Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 35. Amgen Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Aqua Pharmaceuticals Corporate Summary
Table 37. Aqua Pharmaceuticals Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 38. Aqua Pharmaceuticals Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. AstraZeneca Corporate Summary
Table 40. AstraZeneca Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 41. AstraZeneca Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Bristol-Myers Squibb Corporate Summary
Table 43. Bristol-Myers Squibb Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 44. Bristol-Myers Squibb Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Daiichi Sankyo Corporate Summary
Table 46. Daiichi Sankyo Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 47. Daiichi Sankyo Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Elekta Corporate Summary
Table 49. Elekta Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 50. Elekta Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Eli Lilly Corporate Summary
Table 52. Eli Lilly Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 53. Eli Lilly Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Roche Corporate Summary
Table 55. Roche Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 56. Roche Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. GSK Corporate Summary
Table 58. GSK Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 59. GSK Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. iCAD Corporate Summary
Table 61. iCAD Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 62. iCAD Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Bausch Health Corporate Summary
Table 64. Bausch Health Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 65. Bausch Health Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. Merck Corporate Summary
Table 67. Merck Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 68. Merck Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 69. Novartis Corporate Summary
Table 70. Novartis Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 71. Novartis Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 72. Pfizer Corporate Summary
Table 73. Pfizer Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 74. Pfizer Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 75. QIAGEN Corporate Summary
Table 76. QIAGEN Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 77. QIAGEN Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 78. Sanofi Corporate Summary
Table 79. Sanofi Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 80. Sanofi Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 81. Teva Pharmaceutical Corporate Summary
Table 82. Teva Pharmaceutical Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 83. Teva Pharmaceutical Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 84. Varian Medical Systems Corporate Summary
Table 85. Varian Medical Systems Skin Cancer Diagnosis and Therapeutics Product Offerings
Table 86. Varian Medical Systems Skin Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Skin Cancer Diagnosis and Therapeutics Segment by Type in 2021
Figure 2. Skin Cancer Diagnosis and Therapeutics Segment by Application in 2021
Figure 3. Global Skin Cancer Diagnosis and Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Skin Cancer Diagnosis and Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Skin Cancer Diagnosis and Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Skin Cancer Diagnosis and Therapeutics Revenue in 2021
Figure 8. By Type - Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Skin Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Skin Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Skin Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Skin Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Skin Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Skin Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Agilent Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Aqua Pharmaceuticals Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AstraZeneca Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bristol-Myers Squibb Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Daiichi Sankyo Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Elekta Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eli Lilly Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Roche Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GSK Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. iCAD Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Bausch Health Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Merck Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Novartis Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Pfizer Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. QIAGEN Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Sanofi Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Teva Pharmaceutical Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Varian Medical Systems Skin Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)